One-year multicenter, double-masked, placebo-controlled, parallel safety and efficacy study of 2% pirenzepine ophthalmic gel in children with myopia

Gel (2% twice daily) was effective and relatively safe in slowing the progression of myopia over a 1-year treatment period.